Update on the Diagnosis and Treatment of Rare Neuroendocrine Tumors
- 1 April 1987
- journal article
- review article
- Published by Elsevier in Surgical Clinics of North America
- Vol. 67 (2) , 379-393
- https://doi.org/10.1016/s0039-6109(16)44190-3
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Morphologic patterns and diagnostic criteria of VIP-producing endocrine tumors. A histologic, histochemical, ultrastructural, and biochemical study of 32 casesCancer, 1983
- DIARRHOEA IN VIPOMA PATIENTS ASSOCIATED WITH COSECRETION OF A SECOND ACTIVE PEPTIDE (PEPTIDE HISTIDINE ISOLEUCINE) EXPLAINED BY SINGLE CODING GENEThe Lancet, 1983
- Tumors of the Endocrine PancreasNew England Journal of Medicine, 1982
- Ectopic (Inappropriate) Hormone Production by Tumors: Mechanisms Involved and the Biological and Clinical Implications*Endocrine Reviews, 1980
- Familial Hyperglucagonemia — An Autosomal Dominant DisorderNew England Journal of Medicine, 1977
- POSSIBLE DUAL ROLE FOR VASOACTIVE INTESTINAL PEPTIDE AS GASTROINTESTINAL HORMONE AND NEUROTRANSMITTER SUBSTANCEThe Lancet, 1976
- VIP MEASUREMENT IN DISTINGUISHING VERNER‐MORRISON SYNDROME AND PSEUDO VERNER‐MORRISON SYNDROMEClinical Endocrinology, 1976
- Glucagon, gastrin, and carcinoid tumors of the duodenum, pancreas, and stomach: Polypeptide “apudomas” of the foregutThe American Journal of Surgery, 1974
- Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth HormoneScience, 1973
- PANCREATIC CHOLERA DUE TO PRODUCTION OF GASTRIC INHIBITORY POLYPEPTIDEThe Lancet, 1972